Personal cleansing compositions and methods of stabilizing microorganisms

By using ingredients such as betaine in personal cleaning compositions, combining ingredients such as lactic acid and polyols, to form compositions with moderate pH values, the problems of skin irritation and dryness caused by private hygiene products in the prior art are solved, and the problem of skin irritation and dryness in women in the prior art is achieved. The effective antibacterial and skin moisturizing effects of Gram bacteria maintain a healthy microbial balance.

CN118902886APending Publication Date: 2024-11-08RB HEALTH US LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410963305.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2015-10-01
Filing Date
2016-09-30
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing personal cleaning compositions often cause skin irritation and dryness in women's private hygiene, making it difficult to maintain a healthy microbial balance, and the antibacterial effect of the market products is limited and cannot provide long-term skin moisturizing and protective functions.

Method used

A composition comprising betaine surfactant, lactic acid, C2-C6 polyol, alkyl polyethoxycarboxylate, alkyl polyethoxyamide, alkyl ether sulfate and water is used at a pH of Between 3.8-4.5, it provides gentle cleaning and antibacterial protection to maintain the natural microbial balance of the skin.

Benefits of technology

The composition achieves effective antimicrobial effects on fungi, Gram-positive and negative bacteria, provides gentle skin cleansing and moisturizing effects, stabilizes the symbiotic microbial community of the skin, is suitable for daily use, reduces the risk of infection, and is proven by clinical testing. Its safety and durability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004950958090000091
    Figure BDA0004950958090000091
  • Figure BDA0004950958090000111
    Figure BDA0004950958090000111
  • Figure BDA0004950958090000121
    Figure BDA0004950958090000121
Patent Text Reader

Abstract

The present invention relates to personal cleansing compositions and methods of stabilizing microorganisms. The personal cleansing composition provides an effective antimicrobial benefit, comprising: a) 1% by weight to 3% by weight of a betaine surfactant, b) 2% by weight to 5.0% by weight of lactic acid, c) 6% by weight to 20% by weight of glycerol, d) 2% by weight to 7% by weight of an alkyl polyethoxycarboxylate, e) greater than 1% by weight and less than or equal to 3% by weight of a PEG 4 rapeseed amide, f) gt; the present invention relates to a surfactant composition comprising: i) 8% by weight of a surfactant, 8% by weight of an alkyl ether sulfate, g) water, h) a pH of 3.8-4.5, i) 15% by weight to 20% by weight of a total surfactant, and j) 0.1% by weight to 10% by weight of a metal salt.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application. The international application number of the original application is PCT / GB2016 / 000175, the Chinese national application number is 201680067313.6, the application date is September 30, 2016, and the name of the invention is “Personal Cleansing Composition and Method for Stabilizing Microorganisms”. Technical Field

[0002] The present invention relates to personal cleansing compositions which are particularly useful in personal care applications, such as topical skin care, most preferably including cleansing of feminine intimate hygiene products, which compositions exhibit significant antimicrobial benefits, yet are mild and non-irritating to the skin, and provide targeted protection against infection benefits while maintaining a healthy vulvar microbiome balance. Background Art

[0003] Washing is one of the basic requirements of cleanliness in life in terms of dirt removal and hygiene maintenance.

[0004] Daily use of personal hygiene compositions containing certain active agents is known to cause skin irritation and dryness, particularly in the sensitive / intimate areas of the female body. This both limits their frequency of use and often requires the use of corrective skin moisturizers.

[0005] Improper hygiene may contribute to female odour and vulvovaginal infections and problems. Furthermore, maintenance of microbial balance plays a key role in overall vulvovaginal health and preventing pathogens from gaining a foothold. In addition to harsh antimicrobials, factors that interfere with the natural pH levels of the vulvovaginal area may negatively impact the composition of the natural vulvovaginal microbiome required to protect against infection. Proper intimate hygiene is essential for female health. Royal College of Obstetricians and Gynaecologists (RCOG) guidelines and most doctors do not recommend the use of high pH soaps as they may cause dryness or other skin problems.

[0006] Products currently on the market are limited in their ability to provide an appropriate level of antimicrobial action, while others provide too high a level of antimicrobial action for the intimate area and do not provide skin balancing / moisturization. Some products use antiseptics such as triclosan, chlorhexidine, or other antimicrobial / other harsh chemicals to kill bacteria. There is a need in the market for a feminine intimate hygiene formulation that provides antimicrobial action while maintaining a healthy balance of the skin's natural flora, is non-drying to the skin, provides moisturizing benefits, and is suitable for daily use while providing protection for the intimate area.

[0007] The healthy vagina is dominated by Lactobacillus, a non-spore, Gram-positive bacillus that produces lactic acid, creating an acidic environment (pH 3-4). Vaginal pH correlates with total lactate concentrations because the vaginal mucosa is also a rich source of lactate, a byproduct of estrogen-regulated anaerobic glucose metabolism. Normal vaginal flora, acidic vaginal pH, and vaginal secretions are all components of the innate defense mechanism against vulvovaginal infection. The importance of vaginal lactate needs to be emphasized because it is associated with vaginal health, inhibits the growth of bacteria associated with bacterial vaginosis, and may play a role in local immune defense.

[0008] Because of the risks associated with internal washing / doucheing, external feminine washes are considered more suitable for intimate health, particularly those containing lactic acid, which has an acidic pH that increases skin balance and can serve as an adjunct therapy for women with vaginal infections or taking antibiotics.

[0009] The present invention aims to eliminate or alleviate some of the above-mentioned disadvantages. Summary of the invention

[0010] According to a first aspect of the present invention, there is provided a personal cleansing composition which provides effective antimicrobial benefits against fungi, Gram-positive bacteria and Gram-negative bacteria and also provides gentle cleansing of the skin including protection of the skin's commensal microflora, the composition comprising:

[0011] a) 0.1 wt% to 10 wt% of a betaine surfactant,

[0012] b) 0.1% to 5.0% by weight of lactic acid,

[0013] c) 0.1 wt% to 20 wt% of C 2 -C 6 Polyols,

[0014] d) 0 wt% to 10 wt% of the formula RO(CH 2 CH 2 O) k CH 2 COO - M + Alkyl polyethoxy carboxylates, wherein R is C 8 -C 22 alkyl, k is an integer from 0 to 20, and M is a soluble salt-forming cation,

[0015] e) 0 wt% to 10 wt% of the formula RO(CH 2 CH 2 O) k CH2 CONH 2 Alkyl polyethoxyamide, wherein R is C 8 -C 22 alkyl, k is an integer from 0 to 20,

[0016] f) >8% by weight of alkyl ether sulfate,

[0017] g) water,

[0018] h) pH 3.8-4.5,

[0019] i) 10 to 20 wt% of total surfactants,

[0020] j) 0.1 to 10 wt% of a metal salt.

[0021] The composition is preferably used as a feminine hygiene product, but can also be used broadly for personal care or personal cleansing, including liquid hand soaps, body washes, mild shampoos, or child and baby washes.

[0022] The present invention is specifically formulated for use on external skin and mucous membranes, such as the vulva or intimate area, to provide gentle cleansing, freshness, antimicrobial protection to maintain a healthy balance, particularly in the intimate area.

[0023] It has four main advantages: (1) gentle cleansing (2) skin moisturizing (3) mild but effective antimicrobial action against transient organisms and (4) symbiotic microbial balance. This achievement of gentle cleansing and skin moisturizing is significant. In addition, these goals are achieved at an optimal skin pH. In addition, it has been found that the composition of the present invention does not disrupt or damage the natural skin flora and promotes a balanced flora on the user's skin, and further stabilizes the microbiome.

[0024] The composition is preferably in the form of a gel, although the composition may be in different forms. Preferred non-limiting examples of different forms include foams.

[0025] According to a second aspect of the present invention, there is provided a personal cleansing composition in the form of a foam which provides effective antimicrobial benefits against Gram-positive and Gram-negative bacteria, the composition comprising:

[0026] a) 0.1 wt% to 5 wt% of a betaine surfactant,

[0027] b) 0.1% to 5% by weight of lactic acid,

[0028] c) 0.1 wt% to 20 wt% of C 2 -C 6 Polyols,

[0029] d) water,

[0030] e) pH 3.8-4.5,

[0031] f) 0.1 wt% to 5 wt% of total surfactants.

[0032] The density of the foam is preferably less than 500 g / l, more preferably less than 400 g / l, more preferably less than 300 g / l, most preferably less than 200 g / l.

[0033] The foam of the second aspect of the invention may be prepared by the user, for example, in a manual mixing process. Alternatively, the foam of the second aspect of the invention may be prepared using a foaming dispenser, such as the foaming dispenser described in US 6840408, the contents of which are incorporated by reference.

[0034] The compositions in gel or foam form have been found to have an excellent creamy foam state and surprisingly have easy rinsing ability (removal with water).

[0035] The most preferred use is as a feminine (intimate) wash composition.

[0036] When used as a feminine wash formulation, the composition has been found to provide / maximum / optimal antimicrobial benefits, yet is gentle and clinically tested to be mild. The rinse-off formulation has also been clinically proven to be moisturizing, help prevent dryness, and not harm the natural intimate microflora.

[0037] The present invention utilizes natural, biosimilar active lactic acid and provides mild antimicrobial action at the appropriate pH for this area of ​​the body. The present invention further provides balance to the intimate area by maintaining optimal skin pH, moisturized skin and balanced vaginal flora.

[0038] It has been found to protect against key intimate hygiene issues (infections caused by transient bacteria, Group B Streptococcus, odor, irritation, itching, inflammation, pain, discomfort). Protection against Group B Streptococcus is particularly important for pregnant women as it can cause urinary tract infections, upper reproductive tract infections, postpartum endometritis, pneumonia, and postpartum sepsis.

[0039] Thus, according to a third aspect of the invention, there is provided a method for providing a bactericidal benefit to a topical surface, particularly a skin surface, the method comprising the steps of contacting a topical surface on which one or more undesirable pathogens, preferably bacteria, are known or suspected to be present with a composition of the first or second aspect of the invention.

[0040] The compositions of the present invention provide an optimal combination of properties such as antimicrobial (ie, antimicrobial activity), cleansing, conditioning, and moisturizing as well as safety and efficacy, ease of storage and use, and aesthetic properties.

[0041] The compositions / methods of the present invention provide reduction of undesirable microorganisms (particularly reduction of Gram-positive and Gram-negative microorganisms) as a primary technical benefit, while providing secondary benefits including skin conditioning and / or skin cleansing. Further secondary benefits can be provided by the presence of one or more optional components that may be included in the formulations or compositions of the present invention.

[0042] Specific implementation of the first aspect of the present invention

[0043] More preferably, the betaine surfactant is present in an amount of 1 wt% to 3 wt%, most preferably about 1.3 wt%.

[0044] Alkyl betaines are known surfactants which are mainly produced by carboxyalkylation (preferably carboxymethylation) of amine compounds. Typical examples are hexylmethylamine, hexyldimethylamine, octyldimethylamine, decyldimethylamine, dodecylmethylamine, dodecyldimethylamine, dodecylethylmethylamine, C 12 / 14 Coconut oil alkyl dimethylamine, tetradecyl dimethylamine, hexadecyl dimethylamine, stearyl dimethylamine, stearyl ethyl methylamine, oleyl dimethylamine, C 16 / 18 Carboxymethylation products of tallow alkyl dimethylamine and technical mixtures thereof. Alkyl amido betaines, which represent carboxyalkylation products of amidoamines, are also suitable. Typical examples are the reaction products of fatty acids containing 6 to 22 carbon atoms (i.e. caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeolic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid and technical mixtures thereof) and N,N-dimethylaminoethylamine, N,N-dimethylaminopropylamine, N,N-diethylaminoethylamine and N,N-diethylaminopropylamine condensed with sodium chloroacetate.

[0045] Most preferably, the betaine comprises cocamidopropyl betaine.

[0046] More preferably, lactic acid is present in an amount of 0.2 to 8 wt%, more preferably 0.3 to 7 wt%, more preferably 0.4 to 5 wt%, and most preferably 2 to 5 wt%, e.g., about 2.25 wt%.

[0047] More preferably C 2 -C 6 The polyol is present in an amount of 2 to 18 wt%, more preferably 6 to 17 wt%, more preferably 8 to 16 wt%, and most preferably 10 to 15 wt%.

[0048] The most preferred is C 2-C 6 The polyol includes glycerol.

[0049] Most preferably, the alkyl polyethoxy carboxylate is present in an amount of 2% to 7% by weight, most preferably about 4.9% by weight.

[0050] Most preferably, in the alkyl polyethoxy carboxylates, R comprises C 12 Alkyl; K is 11 and M is Na.

[0051] More preferably, the alkyl polyethoxyamide is present in an amount of up to 8 wt%, more preferably up to 5 wt%, more preferably up to 4 wt%, and most preferably up to 3 wt%.

[0052] More preferably, the alkyl polyethoxyamide is present in an amount greater than 0.1 wt %, more preferably greater than 0.2 wt %, more preferably greater than 0.5 wt %, more preferably greater than 1.0 wt %, most preferably greater than 1.5 wt %,

[0053] More preferably, the alkyl polyethoxyamido group comprises PEG 4 rapeseedamide.

[0054] It is preferred that the alkyl ether sulfate is present in an amount > 12 wt%.

[0055] More preferably the metal salt is present in an amount of 0.1 wt% to 5 wt%, more preferably 0.2 wt% to 3 wt%, and most preferably about 2 wt%.

[0056] The metal salt preferably comprises an alkali metal and / or alkaline metal halide. Preferred examples of the alkali metal and / or alkaline metal halide include sodium chloride and / or calcium chloride.

[0057] Most preferably, the alkyl ether sulfate comprises sodium laureth sulphate.

[0058] Specific implementation of the second aspect of the present invention

[0059] More preferably, the betaine surfactant is present in an amount of 0.1 wt% to 2 wt%, most preferably about 0.6 wt%.

[0060] Alkyl betaines are known surfactants which are mainly produced by carboxyalkylation (preferably carboxymethylation) of amine compounds. Typical examples are hexylmethylamine, hexyldimethylamine, octyldimethylamine, decyldimethylamine, dodecylmethylamine, dodecyldimethylamine, dodecylethylmethylamine, C 12 / 14Coconut oil alkyl dimethylamine, tetradecyl dimethylamine, hexadecyl dimethylamine, stearyl dimethylamine, stearyl ethyl methylamine, oleyl dimethylamine, C 16 / 18 Carboxymethylation products of tallow alkyl dimethylamine and technical mixtures thereof. Alkyl amido betaines, which represent carboxyalkylation products of amidoamines, are also suitable. Typical examples are the reaction products of fatty acids containing 6 to 22 carbon atoms (i.e. caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeolic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid and technical mixtures thereof) and N,N-dimethylaminoethylamine, N,N-dimethylaminopropylamine, N,N-diethylaminoethylamine and N,N-diethylaminopropylamine condensed with sodium chloroacetate.

[0061] Most preferably, the betaine comprises cocamidopropyl betaine.

[0062] More preferred is lactic acid present in an amount of 0.2 to 5 wt %, more preferably 0.3 to 5 wt %, more preferably 0.4 to 5 wt %, and most preferably 2 to 5 wt %, for example about 2.75 wt %.

[0063] More preferably C 2 -C 6 The polyol is present in an amount of 2 to 18 wt%, more preferably 6 to 17 wt%, more preferably 8 to 16 wt%, and most preferably 10 to 15 wt%.

[0064] The most preferred is C 2 -C 6 The polyol includes glycerol. DETAILED DESCRIPTION

[0065] Surprisingly, it has been found that the compositions of the present invention achieve satisfactory cleaning and disinfection while avoiding the problems caused by irritation of these sulfur-containing compounds, particularly sulfur-containing surfactants such as sodium lauryl ether sulfate (SLES). SLES is an inexpensive and very effective foaming agent. SLES has also been shown to cause skin irritation. This is particularly important considering that the present invention is primarily preferred for intimate use. For this preferred use, it is clearly advantageous to avoid irritation.

[0066] In more detail, it has been observed that the compositions can be characterized by exhibiting at least 1 log10 reduction of various microorganisms / bacteria such as E. coli when tested according to the standardized testing protocol of ASTM E2315-03 "Standard Guide for Evaluating Antimicrobial Activity Using a Time Kill Procedure".

[0067] Antimicrobial Testing Protocol:

[0068] The antimicrobial efficacy against Gram-positive (Staphylococcus aureus) (ATCC 6538), Gram-negative (Escherichia coli) (ATCC 10536) bacteria and yeast Candida albicans (ATCC 10231) was evaluated using a test protocol according to ASTM E2315-03 "Standard Guide for Evaluating Antimicrobial Activity Using a Time Kill Procedure". According to the protocol, first, a challenge culture (18 hours to 24 hours) is prepared by suspending in trypsin sodium chloride, which is equilibrated to 20°C to 22°C at room temperature. On the day of the test, 5 ml of the composition product sample is mixed with 4 ml of standard hard water (about 300 ppm CaCO) in a sterile container (e.g., a test tube) at room temperature (20°C to 22°C). 3 ) mixed. 1 ml of the test culture was then added, which resulted in a 50% v / v dilution. The test tube was then vortexed for 5 seconds and kept in contact for 60 + / - 5 seconds, after which a 1 ml aliquot was immediately taken out and added to another tube containing 9 ml of neutralizer. Neutralization was allowed to occur for 5 minutes, and then a serial ten-fold dilution using trypsin sodium chloride was plated and incubated at 36 ± 1 ° C for 24 to 48 hours. The inoculum used was also serially diluted, plated and incubated at 36 ± 1 ° C for 24 to 48 hours. After incubation, the surviving colony forming units (CFU) of the stimulating organism were counted, and the log10 reduction value of each test preparation was determined from one or more replicates, and in the case of multiple replicates, the average result was reported.

[0069] pH

[0070] It is contemplated that certain preferred embodiments of the formulations of the invention may also provide antimicrobial or disinfectant benefits facilitated by the low pH of particularly preferred embodiments of the invention, particularly wherein the pH of the composition is between 3.8 and 4.5.

[0071] Viscosity

[0072] The composition of the first aspect of the present invention is viscous and exhibits a viscosity of at least 500 cps at room temperature as measured using a Brookfield viscometer, type 3 spindle at 12 rpm. The composition of the first aspect of the present invention preferably exhibits a viscosity in the range of at least about 500 cps measured under these conditions. More preferably, the topical composition of the present invention exhibits a viscosity of from about 1000 cps to about 10,000 cps, still more preferably from about 1500 cps to 7000 cps, and particularly preferably from about 1500 cps to 4500 cps.

[0073] Although the topical compositions disclosed herein find primary use in application to the skin to provide cleansing and antimicrobial benefits, and are intended to be provided in dispensers for such treatments, it should be understood that this is not a limiting definition and other forms and other uses of the compositions of the present invention, such as creams, lotions, creams, facial cleansing creams, massage materials, liquid soaps, and hair care products such as shampoos, rinses or other hair or scalp treatments are expressly contemplated to be within the scope of the present invention. It should be further expressly understood that the compositions disclosed herein can be topically applied to the skin anywhere on the body, including the face, neck, chest, back, arms, underarms, hands, legs, and scalp.

[0074] Optional components

[0075] Optionally, a chelating agent may be present. The overall level of chelating agent present (when present) may be in the range of 0.1 wt% to 10 wt%.

[0076] Particularly preferred chelating agents for use herein are iminodisuccinic acid or its salts and / or DTPA (diethylenetriaminepentaacetic acid), such as Dequest 2066 (trademark; product available from Solutia Inc., St Louis 6366-6760, USA), EDTA, and Dissolvine (GLDA / glutamic acid diacetate) EDG (trademark; product available from Akzo Nobel, Gillingham, UK),

[0077] Optionally, the composition of the present invention may include other components that can be used to improve one or more aesthetic characteristics of the composition or improve one or more technical characteristics of the composition. Exemplary other optional components include coloring agents, fragrances and fragrance solubilizers, viscosity modifiers including one or more thickeners, pH regulators and pH buffers including organic and inorganic salts, optical brighteners, sunscreens, hydrotropes and preservatives, and other optional components that provide improved technology or aesthetic characteristics known in the relevant art. When present, the total amount of the one or more optional components present in the composition of the present invention is no more than about 10% by weight, preferably no more than 5% by weight, and most preferably no more than 2.5% by weight.

[0078] These aspects and advantages of the present invention will be discussed in more detail below, particularly with reference to one or more embodiments set forth below.

[0079] Example

[0080] Example 1 - Basic Formulation and Antimicrobial Performance

[0081] The table shows the effect of varying the total surfactant, lactic acid and salt concentrations of a base gel body wash formula (E1) on microbial performance. A passing formula is defined as achieving at least 1 log kill against both S. aureus and E. coli when tested according to the standardized test protocol of ASTM E2315-03 "Standard Guide for Evaluating Antimicrobial Activity Using a Time Kill Procedure". A 1 log kill against C. albicans is also preferred given its relevance in the intimate area.

[0082]

[0083] The data demonstrates that a 5% reduction in the total surfactant system resulted in lower E. coli performance based on Example E2. In Example E4, by reducing the lactic acid to 1.75%, the microbial effect was also negatively impacted. Example E3 demonstrated that a positive effect was retained by replacing sodium chloride with calcium chloride. Example E5 demonstrated that a positive effect was retained by replacing 88% lactic acid with 50%. In fact, a 0.5 log increase in Candida albicans kill was noted. It is suspected that this benefit may come from the fact that a more dilute solution of lactic acid is more enriched in the monomeric form of lactic acid, which is more effective than the polymeric form.

[0084] Table A: Components with trade names

[0085] raw material Product Name Tetrasodium Glutamate Diacetate Dissolvine GL 47S Sodium Laureth Sulfate Texapon N70A Sodium lauryl ether 11 carboxylate Akypo Soft 100BVC PEG 4 Rapeseedamide Amidet N Cocamidopropyl Betaine Mackam 35 glycerin Glycerin USP Kosher Benzoic acid, sorbic acid, benzyl alcohol Microcare SBB lactic acid Purac HiPure 90, Ultrapure 50

[0086] It has been found that the E1, E3 and E5 formulations described above:-

[0087] 1. Gentle on the skin and provide appropriate antimicrobial effect, reducing certain germs / bacteria by at least 1 log level.

[0088] 1. Gentle on the skin and provides a stable pH value for intimate skin over 28 days. (The changes within 28 days were not statistically significant).

[0089] 1. Provides moisturizing to the skin. (Within 28 days, the increase in moisturizing of the intimate skin was statistically significant, p<0.05) It was further demonstrated that the increase in moisturizing of keratinized skin was statistically significant after 1 hour (compared with baseline, p<0.05)).

[0090] 1. Respect the natural balance of the colonizing / symbiotic flora in the private area.

[0091] Example 2 - Skin irritation or sensitization studies

[0092] Gel formulation E5 was placed in a clinical study to determine the skin irritation and sensitization potential after external contact with the skin of human subjects.

[0093] The study was conducted in 104 healthy subjects using a semi-occlusive patch containing the test product (diluted to 1%) applied to marked skin sites on the upper back (between the shoulder blades) for nine 24-hour exposure periods during a 3-week induction phase. Skin sites were evaluated for erythema, edema, and other signs of irritation approximately 48 hours after each application. After a rest period of approximately 2 weeks following the induction period, a semi-occlusive product challenge patch was applied to a previously untreated site on the back for 24 hours. Erythema, edema, and other signs of irritation were evaluated at the challenge site 24, 48, and 72 hours after patch application to determine sensitization potential.

[0094] No visible skin reactions were observed.

[0095] The study concluded that based on the test population of 104 subjects and under the conditions of the study, the above identified formula did not demonstrate the potential to cause skin irritation or sensitization, thus supporting that the formula is mild and gentle.

[0096] Example 3 - Comparison of the feminine gel of the present invention with competitive products

[0097] Kora is an intimate hygiene gel product that contains a lactic acid / chamomile antimicrobial complex. However, when tested, the low dose of lactic acid in the Kora product did not provide enough antimicrobial efficacy to promote adequate hygiene of the intimate feminine area. See the results below.

[0098] Sample Information Lactic acid % activity basis Glycerol%, active basis pH Kora 0.08 1.81 5.0–6.0 Preparation E5 of the present invention 2.25 10 4.19

[0099]

[0100] Additionally, the Kora product (similar to many commercial intimate hygiene products) was found to have very low levels of glycerin, which may not provide adequate moisturizing benefit compared to the gel according to the present invention.

[0101] The key to the effective antimicrobial benefit demonstrated by the formulation of the present invention is the three surfactant system with a synergistic effect of high amounts of lactic acid.

[0102] Example 4 - Intimate Foam Cleanser

[0103] Intimate foaming cleansers are another popular feminine product. Lactic acid is again used as the antimicrobial active in the foaming formula. The formulations contain lower amounts of total surfactants than the previous gel examples and also contain higher levels of lactic acid to help balance the microbial effects of the formulation. These formulations are water-dilutable and are available in foam pump packaging or squeeze foam dispensers.

[0104] A passing formulation of the foam is defined as achieving at least 1 log kill against both Staphylococcus aureus and Escherichia coli when tested according to the standardized testing protocol of ASTM E2315-03 "Standard Guide for Evaluating Antimicrobial Activity Using the Time Kill Procedure". A 1 log kill against Candida albicans is also preferred given its relevance in the intimate area.

[0105]

[0106] Example 5 - Tolerance and microbial studies in the use of feminine hygiene cleansers

[0107] After a 7-day pre-study conditioning period with a pH 5.6 shower gel product, 34 healthy female subjects washed their outer intimate area at least once a day with the test product (formulation E5) for 28 days and were evaluated at baseline (day 0) and on days 14 and 28. Gynecologists performed tolerance assessments for dry skin, erythema, edema, scaling, pruritus (verbal questioning of subjects, visual assessment of scratch marks), burning (verbal questioning of subjects), stinging (verbal questioning of subjects) and other clinical signs of irritation in the intimate area. Subjects provided subjective tolerability assessments at baseline (day 0) and on days 14 and 28.

[0108] At baseline (day 0) and on days 14 and 28, skin pH measurements of the labia majora were performed using a skin-pH meter PH 905 probe with the Multi Probe Adaptor system (MPA system) (Courage & Khazaka GmbH). After the subjects were kept in climate-controlled conditions (adapted to 22 ± 2 °C and 35-55% RH), the skin pH of the labia majora was measured using the Multi Probe Adaptor (MPA) 6 with a Corneometer probe. Skin hydration and moisturization measurements were performed using a CM 825 (Courage & Khazaka GmbH) for 20 minutes. Skin hydration in the groin area was measured using a Corneometer at baseline (Day 0) and at Days 14 and 28 to assess longer lasting benefits. Skin moisturization in the upper inner leg area was measured using a Corneometer at two time points before and after application of the test product by a research technician, at baseline (T-0h), T-0 post-cleanse (immediately after test product wash-off) and T-1h after application of the test product wash-off to assess single use benefits / short-term benefits.

[0109] Microbiological samples were collected from the labia majora area by cup swabbing at baseline (day 0) and on days 14 and 28. 2 3.0 cm area) to make firm contact with the skin, applying enough pressure to prevent leakage of liquid during collection. Pipette 1 ml of 0.1% detergent solution (75 mM phosphate buffer buffered to pH 7.5-8.0 containing 0.1% (v / v) Triton X-100 (full strength cleaning solution)) onto the skin around the approximately 3.0 cm 2 The skin surface was carefully rubbed as evenly as possible using a blunt sterile glass rod (scrubber) in a sterile glass cylinder of 1.50 mm in diameter, applying moderate constant pressure for 1 minute. The samples were sterilized by boiling at 96°C for 10 minutes, packaged in dry ice and shipped for microbial diversity analysis.

[0110] Thirty-six (36) subjects were included in the study. Two (2) subjects withdrew, leaving thirty-four (34) subjects who completed the study and whose microbiome data were included in the analysis. The subjects' ages ranged from 19 to 55 years (mean 36.61, SD 11.28). Twelve subjects (33.3%) were between 18 and 29 years old; 13 (36.1%) subjects were between 30 and 44 years old, and 11 (30.6%) subjects were between 45 and 55 years old.

[0111] The skin irritation score (mean total score) based on a 5-point scale, 0 = none, 0.5 = very mild, 1 = mild, 2 = moderate, 3 = severe, increased from 0.01 on day 0 to 0.12 on day 14 and 0.13 on day 28. The subjects' mean baseline total irritation scores on days 14 and 28 were 0.10 and 0.12, respectively, meeting acceptable tolerability criteria. After 28 days of use, the overall tolerability rating given by the gynecologist was: "The test product was well tolerated by most subjects."

[0112] The skin pH of the external intimate area on Day 0 (total population) was 5.88. On Day 14, the pH dropped slightly to 5.87 and to 5.85 on Day 28. The mean change from baseline pH across subjects was -0.01 on Day 14 and -0.03 on Day 28. The analysis showed no significant differences between the time points; the p-value between D-0 and D-14 was 0.992, the p-value between D-0 and D-28 was 0.883, and the p-value between D-14 and D-28 was 0.933; all of which were well above the 95% confidence level of 0.05. Statistical analysis confirmed that there were no significant differences in skin pH over time in the external (vulvar) area with product use (total population).

[0113] The mean Corneometer score for skin hydration measured in the groin area was 39.14 on Day 0. It increased to 45.97 on Day 14 and 48.86 on Day 28. Skin hydration increased during the 28 days of the study. The analysis showed a statistically significant increase (p<0.05) in skin hydration on D-14 and D-28 (p=<0.0001).

[0114] For the test product, skin moisturization as measured by the mean Corneometer score for the upper inner leg region had a statistically significant increase compared to baseline at T-1 hour (p=<0.0001) (34.43 vs. 29.98).

[0115] For microbial diversity analysis, 16S rRNA sequences were amplified, sequenced and OTU (operational taxonomic unit) assigned to each sequence based on the NCBI database.

[0116] Diversity was examined from two perspectives. First, overall richness (i.e., the number of different organisms present within the microbiome) was expressed as the number of operational taxonomic units (OTUs) and quantified using the Chao1 richness estimator.

[0117] Second, overall diversity (determined by richness and evenness, the distribution of abundance among different taxa) was expressed as Shannon diversity.

[0118] Diversity measures for group differences were screened using analysis of variance (ANOVA). The results (shown below) showed that the gel wash formulation tested had no significant effect on species richness and diversity at any time point assessed for bacteria or fungi in the external intimate skin microbiome (p>0.05). In fact, it was shown to stabilize the intimate skin microbiome.

[0119] Table B: Comparison of bacterial alpha diversity indicators at different time points:

[0120] Day 0 (n=34) Day 14 (n=34) Day 28 (n=34) Observed OTUs 222.74 176.47 186.56 Chao1 abundance 246.64±9.64 201.55±10.83 210.2±10.16 Shannon Diversity 2.58 2.37 2.36

[0121] Table C: ANOVA results testing differences in Chao1 abundance between time points:

[0122] Df Total Sq Average Sq F-number Pr(>F) time 2 38932.63 19466.32 2.01 0.1400 Residual 99 960760.90 9704.66

[0123] Table D: ANOVA results, testing differences in Shannon diversity between time points

[0124] Df Total Sq Average Sq F-number Pr(>F) time 2 1.08 0.54 1.19 03097 Residual 99 44.90 0.45 Table E: Comparison of fungal alpha diversity indicators at different time points:

[0125] Day 0 (n=16) Day 14 (n=12) Day 28 (n=13) Observed OTUs 5.06 4.75 186.56 Chao1 abundance 5.08±0.08 4.75±0.04 6.31±0.05 Shannon Diversity 0.37 0.37 0.48

[0126] Table F: ANOVA results testing differences in Chao1 abundance between time points.

[0127] Df Total Sq Average Sq F-number Pr(>F) time 2 17.44 8.72 0.90 0.4169 Residual 38 369.97 9.74

[0128] Table G: ANOVA results testing differences in Shannon diversity between time points.

[0129] Df Total Sq Average Sq F-number Pr(>F) time 2 0.11 0.06 0.44 0.6469 Residual 38 4.92 0.13

[0130] Conclusions: The gel cleanser showed acceptable tolerability, did not significantly alter skin pH in the external vulvar area and provided significant skin hydration and moisturizing benefits when used at least once daily by women over a 4-week period (28 days). In addition, microbiome analysis of the external vulvar area showed that the formula had no significant effect on bacterial or fungal species richness and diversity, with a stabilizing effect on the microbiome.

Claims

1. A personal cleansing composition providing effective antimicrobial benefits against fungi, Gram-positive bacteria and Gram-negative bacteria, the composition comprising: a) 1 to 3 wt% of a betaine surfactant, b) 2% to 5.0% by weight of lactic acid, c) 6 to 20% by weight of glycerol, d) 2 to 7 wt% of the formula RO(CH 2 CH 2 O) k CH 2 COO - M + Alkyl polyethoxy carboxylates, in, R is for C 8 -C 22 alkyl, k is an integer from 0 to 20, and M is a soluble salt-forming cation, e) greater than 1% by weight and less than or equal to 3% by weight of PEG 4 rapeseedamide, f)> 8% by weight of alkyl ether sulfate, g) water, h) pH 3.8-4.5, i) 15 to 20 wt% of total surfactants, and j) 0.1 to 10 wt% of a metal salt.

2. The composition according to claim 1, in, The alkyl polyethoxy carboxylate was present in an amount of 4.8 wt%.

3. The composition according to claim 1, in, In the alkyl polyethoxy carboxylate, R comprises C 12 Alkyl; K is 11 and M is Na.

4. The composition according to claim 1, in, The betaine surfactant was present in an amount of 1.3 wt%.

5. The composition according to claim 1, in, The betaine comprises cocamidopropyl betaine.

6. The composition according to claim 1, in, The lactic acid was present in an amount of 2.25 wt%.

7. The composition according to claim 1, in, The glycerol is present in an amount of 6 wt % to 17 wt %.

8. The composition according to claim 7, in, The glycerol is present in an amount of 8 wt % to 16 wt %.

9. The composition according to claim 8, in, The glycerol is present in an amount of 10 wt % to 15 wt %.

10. The composition according to claim 1, in, The metal salt is present in an amount of 0.1 wt% to 5 wt%.

11. The composition according to claim 10, in, The metal salt is present in an amount of 0.2 wt% to 3 wt%.

12. The composition according to claim 11, in, The metal salt was present in an amount of 2% by weight.

13. The composition of claim 1, in, The metal salt comprises an alkali metal and / or an alkaline metal halide.

14. The composition of claim 1, in, The alkyl ether sulfate comprises sodium lauryl ether sulfate.

15. Use of a composition as claimed in any one of claims 1 to 14 in the manufacture of a composition for providing a bactericidal benefit to a topical surface.

16. Use of a composition as claimed in any one of claims 1 to 14 in the manufacture of a composition for providing a microbicidal benefit to a topical surface without disrupting or disturbing the natural balance of microflora or microbiome on the skin surface.

17. Use of the composition according to any one of claims 1 to 14 for producing a composition for stabilizing the pH of a surface.

18. Use of the composition according to any one of claims 1 to 14 for producing a composition for stabilizing a microbial group or microbial community on a surface.

19. Use of the composition according to any one of claims 1 to 14 for producing a composition for moisturizing a surface.

20. The use according to any one of claims 15 to 19, wherein the surface is a skin surface.

21. Use according to claim 20, wherein the surface is an intimate skin / external surface.